In Quick Succession: Wave Of New Leaders Could Reshape Industry

Numerous Major Off-Patent Players Have Announced New Leadership In Recent Months

With a number of top generics and biosimilars firms announcing new leaders over the past few months, the industry could be in for some strategic shifts as new faces take the helm at established off-patent players.

New Leader, New Ideas - Lightbulb icon on wooden blocks
New generics and biosimilars industry leaders could bring fresh thinking • Source: Shutterstock

Ask an industry onlooker what the following companies have in common – Teva, Viatris, Apotex, Fresenius Kabi, Hikma, Zentiva, Alvotech, Nichi-Iko, Biocon Biologics and Padagis – and they might answer that these firms are among the leading generics and biosimilars players around the world.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Leadership

More from Generics Bulletin